According to GuruFocus Insider Data, these were the largest CEO buys during the past week.
Darden Restaurants
Darden Restaurants Inc. (DRI, Financial) President and CEO Eugene I. Lee Jr. bought 25,641 shares on April 23 at a price of $58.50. The price of the stock has increased by 17.64% since then.
Darden is one of the largest players in the $185 billion U.S. casual dining industry. Olive Garden (870 units), LongHorn (522) and Cheddar's Scratch Kitchen (169 company-owned units) are its core brands, while the smaller, faster-growing specialty restaurant group is made up of Yard House (81), The Capital Grille (60), Seasons 52 (45), Bahama Breeze (42) and Eddie V's (23).
The company has a market cap of $8.32 billion. Its shares traded at $68.82 with a price-earnings ratio of 13.43 as of April 24.
Third quarter net earnings for fiscal 2020 were $232.3 million compared to $223.6 million for the prior-year period.
Senior Vice President and Chief Financial Officer Ricardo Cardenas bought 2,991 shares on April 23 at a price of $58.50. Since then, the price of the stock has increased by 17.64%.
President of LongHorn Steakhouse Todd Burrowes bought 2,564 shares on April 23 at a price of $58.50. The price of the stock has increased by 17.64% since then.
Director Cynthia T. Jamison bought 3,418 shares on April 23 at a price of $58.50. Since then, the price of the stock has increased by 17.64%.
Executive Vice President and Chief Operating Officer David C. George bought 4,273 shares on April 23 at a price of $58.50. The price of the stock has increased by 17.64% since then.
Director James P. Fogarty bought 4,273 shares on April 23 at a price of $58.50. Since then, the price of the stock has increased by 17.64%.
Director Charles M. Sonsteby bought 12,820 shares on April 23 at a price of $58.50. The price of the stock has increased by 17.64% since then.
OPKO Health
OPKO Health Inc. (OPK, Financial) CEO, Chairman and 10% Owner Phillip Frost bought 325,000 shares on April 17 at a price of $1.66. Since then, the price of the stock has increased by 24.1%.
OPKO Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. It has a development and commercial supply pharmaceutical company, a global supply-chain operation and holding company and a specialty active pharmaceutical ingredients manufacturer in Israel.
The company has a market cap of $1.38 billion. Its shares traded at $2.06 as of April 24. Net loss for the fourth quarter of 2019 was $112.4 million compared with a net loss of $76.1 million for the comparable period of 2018.
Frost bought 50,000 shares on April 3 at a price of $1.15; 400,000 shares on April 7 at a price of $1.28; 200,000 shares on April 15 at a price of $1.55; and 25,000 shares on April 16 at a price of $1.63. The price of the stock has increased by 26.38% since then.
For the complete list of stocks bought by their company CEOs, go to: CEO Buys.
Disclosure: I do not own stock in any of the companies mentioned in the article.
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
